These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 11789260
1. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule]. Chen H, Weng L. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):255-7. PubMed ID: 11789260 [Abstract] [Full Text] [Related]
2. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS, Wang BE, Wang TL, Jia JD, Qian LX. Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205 [Abstract] [Full Text] [Related]
3. [Clinical observation on effect of xuefu zhuyu decoction in treating patients with liver fibrosis caused by chronic hepatitis B]. Ru QJ, Tang ZM, Zhang ZE, Zhu Q. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Nov; 24(11):983-5. PubMed ID: 15609594 [Abstract] [Full Text] [Related]
4. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study]. Liu SY, Zhang YQ, Liu YL, Guo P, Zhou CM. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1457-61. PubMed ID: 24483103 [Abstract] [Full Text] [Related]
5. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases]. Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW. Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637 [Abstract] [Full Text] [Related]
6. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction]. Liang TJ, Zhang W, Zhang CQ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):332-4. PubMed ID: 12584827 [Abstract] [Full Text] [Related]
7. [Diagnostic value of five serum markers for liver fibrosis]. Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388 [Abstract] [Full Text] [Related]
8. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment]. Hu YY, Liu P, Liu C. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166 [Abstract] [Full Text] [Related]
9. Effects of da ding feng zhu decoction in 30 cases of liver fibrosis. Li W, Wang C, Zhang J. J Tradit Chin Med; 2003 Dec; 23(4):251-4. PubMed ID: 14719288 [Abstract] [Full Text] [Related]
10. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. Chen YP, Feng XR, Dai L, Ding HB, Zhang L. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522 [Abstract] [Full Text] [Related]
11. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B. Liu J, Ji Y, Ai H, Ning B, Zhao J, Zhang Y, Dun G. Korean J Radiol; 2016 Apr; 17(3):396-404. PubMed ID: 27134527 [Abstract] [Full Text] [Related]
12. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. Zheng M, Cai WM, Weng HL, Liu RH. World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928 [Abstract] [Full Text] [Related]
13. [Clinical study on treatment of liver fibrosis by different dosages of Salvia injection]. She SF, Huang XZ, Tong GD. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jan; 24(1):17-20. PubMed ID: 14976882 [Abstract] [Full Text] [Related]
14. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K. J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050 [Abstract] [Full Text] [Related]
15. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy]. Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL. Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710 [Abstract] [Full Text] [Related]
16. [Serum fibrosis markers in diagnosing liver fibrosis]. Liu J, Wang JY, Lu Y. Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325 [Abstract] [Full Text] [Related]
17. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B]. Ding H, Chen Y, Feng X, Liu D, Wu A, Zhang L. Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682 [Abstract] [Full Text] [Related]
18. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739 [Abstract] [Full Text] [Related]
19. [The detection and clinical significance of hepatic fibrosis index]. Xu CH, Meng DM, Lv SL, Kang P. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):50-2. PubMed ID: 20848851 [Abstract] [Full Text] [Related]
20. [Clinical study on relationship between liver-blood stasis and liver fibrosis]. Tang ZM, Ru QJ, Zhang ZE. Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Feb; 17(2):81-3. PubMed ID: 9812662 [Abstract] [Full Text] [Related] Page: [Next] [New Search]